Rhenman & Partners Asset Management AB grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 24.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 95,000 shares of the pharmaceutical company’s stock after purchasing an additional […]
Provident Investment Management Inc. decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 160,319 shares of the pharmaceutical company’s stock after selling 850 shares during the quarter. Vertex […]
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-four research firms that are currently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and fifteen have issued a […]
Portfolio Design Labs LLC acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 9,928 shares of the pharmaceutical company’s stock, valued at approximately $4,040,000. Vertex Pharmaceuticals accounts for […]
Davis R M Inc. bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 492 shares of the pharmaceutical company’s stock, valued at approximately $200,000. A number of other hedge funds and […]